Table 2.

Prevalence of mutations in the MAPK pathway in ATC

Mutation	Positive/ total cases	Prevalence (%)	Reference
BRAFV600E	0/7	0	[51]
	2/6	33	[52]
	3/29	10	[53]
	2/10	20	[54]
	8/16	50	[55]
	0/4	0	[56]
	6/17	35	[57]
Overall BRAFV600E	21/89	23
RAS	4/50	8	[44]
	2/18	11	[58]
	1/5	20	[59]
	4/18	23	[43]
	15/29	55	[60]
	4/50	8	[61]
	3/5	60	[62]
Overall RAS mutations	33/162	20
RET/PTC	0/14	0	[63]
	3/51	6	[44]
	0/17	0	[64]
Overall RET/PTC	3/81	4